Iltefat H Hamzavi
Overview
Explore the profile of Iltefat H Hamzavi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
140
Citations
1215
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Benner J, Adair N, Hitt B, Nguyen V, Hamzavi I, Sussman M
J Med Econ
. 2025 Mar;
28(1):425-435.
PMID: 40042162
Introduction: A cell harvesting device for preparing non-cultured autologous skin cell suspension (ASCS) at the point-of-care is FDA-approved for repigmentation of stable depigmented vitiligo lesions in patients 18 years and...
2.
Lane B, Hamzavi I, Lim H, Rodrigues M, Elbuluk N, Mohammad T
Int J Dermatol
. 2025 Jan;
64(3):485-489.
PMID: 39817312
Few studies discuss the co-management of vitiligo and acquired hyperpigmentation disorders (AHD) such as melasma, erythema dyschromicum perstans, post-inflammatory hyperpigmentation, drug-induced hyperpigmentation, and lichen planus pigmentosus. This review discusses clinical...
3.
Harris J, Pandya A, Lebwohl M, Hamzavi I, Grimes P, Gottlieb A, et al.
Skin Health Dis
. 2024 Dec;
4(6):e404.
PMID: 39624731
No abstract available.
4.
Xue G, Hamzavi I, Kohli I, Mohammad T
Int J Dermatol
. 2024 Aug;
63(9):e221-e222.
PMID: 39215428
No abstract available.
5.
Hamzavi I, Ganesan A, Mahmoud B, Weiss E, Ahmed A, Robinson D, et al.
J Am Acad Dermatol
. 2024 Aug;
91(6):1104-1112.
PMID: 39182674
Background: Vitiligo lesions are often challenging to repigment with conventional medical therapies. Surgical autologous melanocyte transfer methods can be utilized for stable vitiligo but demand specialized skills and equipment. A...
6.
Bibeau K, Butler K, Wang M, Skaltsa K, Hamzavi I
Dermatol Ther (Heidelb)
. 2024 Jul;
14(8):2223-2234.
PMID: 39078582
Introduction: This study reports psychometric testing of the facial and total Vitiligo Area Scoring Index quantitative clinical instruments (F-VASI [range: 0-3], T-VASI [range: 0-100], respectively) using data from two phase...
7.
Bardhi R, Mokhtari M, Masood M, Abdel-Gadir D, McGowan D, Failla O, et al.
Photodermatol Photoimmunol Photomed
. 2024 Jul;
40(5):e12992.
PMID: 39074312
Background: Tinted sunscreens not only shield against UV rays but also provide protection against visible light, as opposed to traditional sunscreens. Universal tinted sunscreens are marketed to complement all skin...
8.
Bouazzi D, Andersen R, Vinding G, Medianfar C, Nielsen S, Saunte D, et al.
Dermatology
. 2024 Feb;
240(3):369-375.
PMID: 38354718
Introduction: Data concerning the global burden of hidradenitis suppurativa (HS) are limited. Reported prevalence estimates vary between 0.0003% and 4.1%, and data from various geographical regions are still to be...
9.
Kohli I, Ceresnie M, Teklehaimanot F, Lane B, Huggins R, Hamzavi I, et al.
Photodermatol Photoimmunol Photomed
. 2024 Jan;
40(1):e12941.
PMID: 38288774
No abstract available.
10.
Ezekwe N, Pourang A, Lyons A, Narla S, Atyam A, Zia S, et al.
Photodermatol Photoimmunol Photomed
. 2023 Dec;
40(1):e12937.
PMID: 38069506
Background: Long wavelength ultraviolet-A1 in combination with visible light induces hyperpigmentation, particularly in dark-skin phototypes. This study evaluated the efficacy of four sunscreen formulations in protecting against VL + UVA1...